Blood glucose level can predict cardiovascular risk

January 03, 2001

A study in this week's BMJ shows that the concentration of glucose in the blood resembles blood pressure and blood cholesterol in terms of predicting cardiovascular risk. These findings have important implications for public health and may provide a practical screening tool for diabetes or impaired glucose tolerance.

Researchers in Cambridge identified 4,662 men aged 45-79 years who had attended a health examination and had their blood glucose concentration measured as part of the European Prospective Investigation of Cancer and Nutrition in Norfolk. Men with known diabetes had greater risk of dying from all causes, cardiovascular disease, and ischaemic heart disease compared with men without diabetes. Risk of death increased with increasing blood glucose concentrations. Even in men without diabetes, blood glucose concentration was related to risk of death, with the lowest rates in those with concentrations below 5%.

Blood glucose concentration seems to resemble blood pressure and blood cholesterol in terms of the continuous relation with cardiovascular risk, say the authors. These findings have important implications for public health: a reduction of just 0.1% or 0.2% blood glucose concentration in the whole population would reduce total mortality by 5% and 10% respectively, they explain.

Preventative efforts need to consider not just those with established diabetes, but whether it is possible to reduce the population distribution of blood glucose concentration through simple lifestyle changes, such as diet or physical activity, they conclude.
Contact: Kay-Tee Khaw, Professor of Clinical Gerontology, Institute of Public Health, University of Cambridge, UK Tel: 44-0-1223-217-292 Fax: 44-0-1223-336-928 Email:

(Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)) BMJ Volume 322, pp 15-18

This release is reproduced verbatim and with permission from the British Medical Association as a service to reporters interested in health and behavioral change. Please contact Public Affairs Division for the text of the paper, and the authors direct for further comment. For further information about The British Medical Journal or to obtain a copy of the article, please contact Public Affairs Division, British Medical Association, BMA House, Tavistock Square, London WC1H 9JP, Tel: 020-7383-6254 or email: After 6 p.m. and on weekends telephone: 44-0-208-241-6386/44-0-208-997-3653/44-0-208-674-6294/44-0-1525-379792/44-0208-651-5130.

Posted by the Center for the Advancement of Health For more research news and information, go to our special section devoted to health and behavior in the "Peer-Reviewed Journals" area of Eurekalert!, For information about the Center, call Petrina Chong, 202-387-2829.

Center for Advancing Health

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to